T cell immunity in autoimmune hepatitis

被引:110
作者
Ichiki, Y
Aoki, CA
Bowlus, CL
Shimoda, S
Ishibashi, H
Gershwin, ME
机构
[1] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA
[2] Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan
[3] Nagasaki Med Ctr, Clin Res Ctr, Nagasaki 8568562, Japan
[4] Univ Calif Davis, Dept Internal Med, Div Gastroenterol, Davis, CA 95616 USA
关键词
autoimmune hepatitis; T cell receptor; autoreactive T cells; molecular mimicry; autoantibodies;
D O I
10.1016/j.autrev.2005.01.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cells play a central role in the immunopathogenesis of AM. Until recently CD4(+) T cells were thought to be critical for disease development, increasing evidence has shown that CD8(+) T and gamma delta T cells also play a significant role. The predisposition of certain HLA genotypes to AM as well as the clonal expansion of a limited number of T cell receptors suggests that the presentation of a self-antigen or a molecular mimic may be responsible for the initiation of the immune response. Given the association of AIH with viral hepatitis, it is thought that the loss of tolerance begins with an infection of hepatocytes and subsequent cytolysis by CD8(+) T cells. The presentation of self-antigens or molecular mimics leads to activation and clonal expansion of T cells; this process may be increased by impaired regulatory T cells and a defect in apoptosis. Ultimately T cells initiate B cell production of autoantibodies, proinflammatory cytokines and finally hepatocyte cytotoxicity. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:315 / 321
页数:7
相关论文
共 40 条
  • [1] International Autoimmune Hepatitis Group Report:: review of criteria for diagnosis of autoimmune hepatitis
    Alvarez, E
    Berg, PA
    Bianchi, FB
    Bianchi, L
    Burroughs, AK
    Cancado, EL
    Chapman, RW
    Cooksley, WGE
    Czaja, AJ
    Desmet, VJ
    Donaldson, RT
    Eddleston, ALWF
    Fainboim, L
    Heathcote, J
    Homberg, JC
    Hoofnagle, JH
    Kakumu, S
    Krawitt, EL
    Mackay, IR
    MacSween, RNM
    Maddrey, WC
    Manns, MP
    McFarlane, IG
    zum Büschenfelde, KHM
    Mieli-Vergani, G
    Nakanuma, Y
    Nishioka, M
    Penner, E
    Porta, G
    Portmann, BC
    Reed, WD
    Rodes, J
    Schalm, SW
    Scheuer, PJ
    Schrumpf, E
    Seki, T
    Toda, G
    Tsuji, T
    Tygstrup, N
    Vergani, D
    Zeniya, M
    [J]. JOURNAL OF HEPATOLOGY, 1999, 31 (05) : 929 - 938
  • [2] [Anonymous], J HEPATOL S
  • [3] Limited T cell receptor Vβ-chain repertoire of liver-infiltrating T cells in autoimmune hepatitis
    Arenz, M
    zum Büschenfelde, KHM
    Löhr, HF
    [J]. JOURNAL OF HEPATOLOGY, 1998, 28 (01) : 70 - 77
  • [4] T cell receptor Vβ chain restriction and preferred CDR3 motifs of liver-kidney microsomal antigen (LKM-1)-reactive T cells from autoimmune hepatitis patients
    Arenz, M
    Pingel, S
    Schirmacher, P
    zum Büschenfelde, KHM
    Löhr, HF
    [J]. LIVER, 2001, 21 (01): : 18 - 25
  • [5] HEPATOCELLULAR EXPRESSION OF LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN-3 IN CHRONIC HEPATITIS
    AUTSCHBACH, F
    MEUER, SC
    MOEBIUS, U
    MANNS, M
    HESS, G
    ZUMBUSCHENFELDE, KHM
    THOENES, W
    DIENES, HP
    [J]. HEPATOLOGY, 1991, 14 (02) : 223 - 230
  • [6] Bogdanos DP, 2001, AM J GASTROENTEROL, V96, P3447
  • [7] COCHRANE AMG, 1976, LANCET, V1, P441
  • [8] Histological features associated with relapse after corticosteroid withdrawal in type 1 autoimmune hepatitis
    Czaja, AJ
    Carpenter, HA
    [J]. LIVER INTERNATIONAL, 2003, 23 (02) : 116 - 123
  • [9] Dalekos G N., 2002, Eur J Intern Med, V13, P293, DOI 10.1016/S0953-6205(02)00089-4
  • [10] EGGINK HF, 1982, CLIN EXP IMMUNOL, V50, P17